IL247152A0 - Preparations and methods for the treatment of diabetes and liver diseases - Google Patents
Preparations and methods for the treatment of diabetes and liver diseasesInfo
- Publication number
- IL247152A0 IL247152A0 IL247152A IL24715216A IL247152A0 IL 247152 A0 IL247152 A0 IL 247152A0 IL 247152 A IL247152 A IL 247152A IL 24715216 A IL24715216 A IL 24715216A IL 247152 A0 IL247152 A0 IL 247152A0
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- methods
- treating diabetes
- liver diseases
- liver
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 208000019423 liver disease Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461939961P | 2014-02-14 | 2014-02-14 | |
| US201461984225P | 2014-04-25 | 2014-04-25 | |
| US201462086911P | 2014-12-03 | 2014-12-03 | |
| PCT/US2015/015353 WO2015123256A1 (en) | 2014-02-14 | 2015-02-11 | Compositions and methods for treating diabetes and liver diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL247152A0 true IL247152A0 (en) | 2016-09-29 |
Family
ID=53800574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL247152A IL247152A0 (en) | 2014-02-14 | 2016-08-07 | Preparations and methods for the treatment of diabetes and liver diseases |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20170165286A1 (enExample) |
| EP (1) | EP3105234A4 (enExample) |
| JP (2) | JP6553067B2 (enExample) |
| KR (1) | KR20160113307A (enExample) |
| CN (1) | CN106132969A (enExample) |
| AU (1) | AU2015217293A1 (enExample) |
| CA (1) | CA2939076A1 (enExample) |
| IL (1) | IL247152A0 (enExample) |
| MX (1) | MX2016010447A (enExample) |
| RU (1) | RU2016133471A (enExample) |
| WO (1) | WO2015123256A1 (enExample) |
| ZA (1) | ZA201606199B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008316830B2 (en) | 2007-10-25 | 2016-03-17 | Cempra Pharmaceuticals, Inc. | Process for the preparation of macrolide antibacterial agents |
| CN107854477A (zh) | 2008-10-24 | 2018-03-30 | 森普拉制药公司 | 使用含三唑的大环内酯治疗抗性疾病的方法 |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| WO2013148891A1 (en) | 2012-03-27 | 2013-10-03 | Cempra Pharmaceuticals, Inc. | Parenteral formulations for administering macrolide antibiotics |
| ES2795450T3 (es) | 2012-09-17 | 2020-11-23 | Madrigal Pharmaceuticals Inc | Procedimiento para sintetizar análogos de hormonas tiroideas y polimorfos de los mismos |
| WO2014152326A1 (en) | 2013-03-14 | 2014-09-25 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
| MX394463B (es) | 2016-10-18 | 2025-03-19 | Madrigal Pharmaceuticals Inc | Métodos para tratar trastornos del hígado o trastornos lipídicos con un agonista de thr-beta. |
| WO2018094265A2 (en) * | 2016-11-21 | 2018-05-24 | Viking Therapeutics, Inc. | Method of treating glycogen storage disease |
| JP2024044227A (ja) * | 2022-09-20 | 2024-04-02 | 国立大学法人岩手大学 | グルコース産生抑制剤 |
| US12377104B1 (en) | 2024-02-06 | 2025-08-05 | Madrigal Pharmaceuticals, Inc. | Methods for treating a fatty liver disease |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5760010A (en) * | 1995-01-01 | 1998-06-02 | Klein; Ira | Method of treating liver disorders with a macrolide antibiotic |
| CA2292359C (en) * | 1999-01-28 | 2004-09-28 | Pfizer Products Inc. | Novel azalides and methods of making same |
| FR2897154B1 (fr) * | 2006-02-08 | 2008-03-07 | Airbus France Sas | Dispositif pour construire et securiser une trajectoire de vol a basse altitude destinee a etre suivie par un aeronef. |
| JP5126685B2 (ja) * | 2006-05-01 | 2013-01-23 | 大正製薬株式会社 | マクロライド誘導体 |
| JP5025249B2 (ja) * | 2006-12-15 | 2012-09-12 | Ｎｓｋワーナー株式会社 | 発進クラッチ |
| JP5150740B2 (ja) * | 2011-01-21 | 2013-02-27 | 株式会社小松製作所 | 作業車両 |
| CN103649088B (zh) * | 2011-08-30 | 2016-05-11 | 沃克哈特有限公司 | 1, 6- 二氮杂双环[3, 2, 1]辛- 7- 酮衍生物及其在治疗细菌感染中的用途 |
| US9078975B2 (en) * | 2011-09-30 | 2015-07-14 | Becton Dickinson France, S.A.S. | Syringe having pivoting arm plunger rod |
-
2015
- 2015-02-11 WO PCT/US2015/015353 patent/WO2015123256A1/en not_active Ceased
- 2015-02-11 US US15/118,124 patent/US20170165286A1/en not_active Abandoned
- 2015-02-11 JP JP2016550869A patent/JP6553067B2/ja active Active
- 2015-02-11 MX MX2016010447A patent/MX2016010447A/es unknown
- 2015-02-11 AU AU2015217293A patent/AU2015217293A1/en not_active Abandoned
- 2015-02-11 KR KR1020167025193A patent/KR20160113307A/ko not_active Ceased
- 2015-02-11 RU RU2016133471A patent/RU2016133471A/ru not_active Application Discontinuation
- 2015-02-11 CN CN201580015346.1A patent/CN106132969A/zh active Pending
- 2015-02-11 EP EP15749185.3A patent/EP3105234A4/en not_active Withdrawn
- 2015-02-11 CA CA2939076A patent/CA2939076A1/en not_active Abandoned
-
2016
- 2016-08-07 IL IL247152A patent/IL247152A0/en unknown
- 2016-09-07 ZA ZA2016/06199A patent/ZA201606199B/en unknown
-
2019
- 2019-07-03 JP JP2019124815A patent/JP2019189639A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP6553067B2 (ja) | 2019-07-31 |
| RU2016133471A3 (enExample) | 2018-09-24 |
| JP2017505785A (ja) | 2017-02-23 |
| EP3105234A4 (en) | 2017-11-08 |
| EP3105234A1 (en) | 2016-12-21 |
| AU2015217293A1 (en) | 2016-09-01 |
| RU2016133471A (ru) | 2018-03-19 |
| ZA201606199B (en) | 2020-01-29 |
| US20170165286A1 (en) | 2017-06-15 |
| MX2016010447A (es) | 2016-12-20 |
| CA2939076A1 (en) | 2015-08-20 |
| WO2015123256A1 (en) | 2015-08-20 |
| KR20160113307A (ko) | 2016-09-28 |
| JP2019189639A (ja) | 2019-10-31 |
| CN106132969A (zh) | 2016-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2500001I1 (hu) | Antitestkészítmények daganatkezelésre | |
| IL247003A0 (en) | Isoindoline compounds and methods for the treatment of neurodegenerative diseases | |
| SG11201705093UA (en) | Composition for treating il-6-related diseases | |
| SG10202109655VA (en) | Compositions and methods for immunooncology | |
| IL246791A0 (en) | Compositions and methods for treating eye diseases | |
| SG11201701723XA (en) | Methods of treating liver disease | |
| SMT202100273T1 (it) | Metodi e composizioni per il trattamento del cancro | |
| ZA201606199B (en) | Compositions and methods for treating diabetes and liver diseases | |
| IL246879B (en) | Preparations of Epilimod and methods of using them | |
| EP3139928A4 (en) | Anordrin compositions and methods for treating diseases | |
| EP3110446A4 (en) | Methods and compositions for treating siglec-8 associated diseases | |
| EP3132795A4 (en) | Composition for preventing or treating fatty liver diseases | |
| EP3142699A4 (en) | Compositions and methods for treating metabolic disorders | |
| SG11201704829QA (en) | Methods and compositions for treating brain diseases | |
| ZA201703398B (en) | Pharmaceutical composition and methods | |
| PT3113774T (pt) | Composições de grapiprant e métodos de utilização das mesmas | |
| ZA201606673B (en) | Compositions and methods for treating neurodegenerative diseases | |
| EP3164132A4 (en) | Methods and compositions for treating diseases and conditions | |
| SG11201609522TA (en) | Methods for treating cardiovascular diseases | |
| ZA201608406B (en) | Enzyme treatment composition | |
| EP3104896A4 (en) | Compositions and methods for treating liver injury | |
| IL252707B (en) | Compositions and methods for treating diseases | |
| PT3210628T (pt) | Métodos para complexos de frutoborato | |
| PL2990058T3 (pl) | Ulepszone kompozycje i sposoby dla kompleksów fruktoboranowych | |
| HK1230194A1 (en) | Compositions and methods for treating diabetes and liver diseases |